Project Statistics: This research is sponsored by FEDER funds through the program COMPETE–Programa Operacional Factores de Competitividade and by the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Funding UID/FIS/04650/2019, andUID/EMS/00285/2013 and in the framework of PTDC/CTM-NAN/4242/2014 and PTDC/NAN-MAT/30789/2017. The authors also thank the financial support by the Portuguese Foundation for Science and Technology (FCT) in the framework of the HEALTHYDENT (co-financed via FEDER (PT2020) POCI-01-0145-FEDER-030708 and FCT (PIDDAC) and the NANOXYPACK POCI-01-0145-FEDER-030789 projects. This research was supported by Norte Regional Operational Program 2014-2020 (Norte2020) through the European Regional Development Fund (ERDF) Nanotechnology-based functional solutions (NORTE-01-0145-FEDER-000019) and through European Social Fund (FSE), under the National Doctoral Program in “Surfaces Engineering and Protection”, NORTE-08-5369-FSE-000047. The authors would like to acknowledge the EU Framework Programme for Research and Innovation H2020, scheme COFUND – Co-funding of Regional, National and International Programmes, under Grant Agreement 713640. The CENTRO Program is also acknowledged through the projects MATIS - CENTRO-01-0145-FEDER-000014 and On-Surf - POCI-01-0247-FEDER-024521.
Geo Map
Region
#
NA - North America
32
AS - Asia, other
14
EU - Europe
1
Total
47
Country
#
US - United States of America
32
CN - China
14
DE - Germany
1
Total
47
City
#
Ashburn
14
Inglewood
11
New York
2
Seattle
1
Unknown
19
Total
47
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2024
5 17
3 4 10 3
0 1 2 2
0 0
47
Ever
47
Geo Map
Region | # |
---|---|
NA - North America | 32 |
AS - Asia, other | 14 |
EU - Europe | 1 |
Total | 47 |
Country | # |
---|---|
US - United States of America | 32 |
CN - China | 14 |
DE - Germany | 1 |
Total | 47 |
City | # |
---|---|
Ashburn | 14 |
Inglewood | 11 |
New York | 2 |
Seattle | 1 |
Unknown | 19 |
Total | 47 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 5 | 17 | 3 | 4 | 10 | 3 | 0 | 1 | 2 | 2 | 0 | 0 | 47 |
Ever | 47 |